Philip Morris International Inc (PM)

Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.

• Relazione annuale (10-K)

  Una panoramica annuale del business, dei risultati finanziari e dei rischi dell'azienda.

  Depositato il 2026-02-06

  Vedi documento

• Relazione trimestrale (10-Q)

  Un aggiornamento sull'andamento finanziario degli ultimi tre mesi.

  Depositato il 2026-07-24

  Vedi documento

• Comunicazione price-sensitive (8-K)

  Una comunicazione su un evento importante, come un cambio ai vertici o un grande annuncio.

  Depositato il 2026-09-18

  Vedi documento

• 21d agoPOSITIVE
  Philip Morris CEO Is ‘Optimistic’ About Zyn Potential

  Philip Morris International CEO Jacek Olczak expressed optimism regarding the growth potential of Zyn, a nicotine pouch product. He highlighted strong demand and discussed the company's year-end market share targets for Zyn. The potential introduction of larger cans, containing 15 to 20 pouches, was also explored as a strategy to enhance revenue and profit margins. This positive outlook on Zyn's performance and strategic expansion could signal continued growth for Philip Morris International, potentially influencing investor sentiment positively.

• 6/2/2026NEGATIVE
  Philip Morris Cuts Outlook on $500 Million Canada Writedown

  Philip Morris International Inc. has revised its full-year profit forecast downwards, citing a substantial $500 million writedown on its investment in its Canadian affiliate. This significant impairment charge indicates potential underperformance or strategic challenges within its Canadian operations. Investors will be closely monitoring the company's ability to navigate these issues and recover profitability. The writedown raises concerns about the company's international segment performance and could lead to a reassessment of its growth trajectory and risk factors.

• 4/22/2026POSITIVE
  What's Going On With Philip Morris Stock Today?

  Philip Morris International Inc. (PM) shares surged following a robust earnings report that surpassed analyst expectations. The company's performance was primarily fueled by significant growth in its smoke-free product category, which continues to offset challenges elsewhere. Despite this strong quarterly showing, Philip Morris has slightly lowered its full-year earnings guidance, a move that may temper some of the immediate enthusiasm. However, the core strength in its next-generation products signals a successful transition strategy, offering a positive outlook for long-term investors focused on the company's evolving portfolio.

• 4/1/2026NEGATIVE
  Philip Morris Stock Falls As Zyn Delays Threaten Major Growth Engine

  Philip Morris International (PM) saw its stock price decline following reports that the FDA's expedited review process for new nicotine pouch applications has been delayed. This slowdown directly impacts the growth trajectory of Zyn, a key product for the company's future revenue streams. The delay raises concerns about the pace of market expansion and regulatory hurdles, potentially affecting investor confidence in PM's ability to capitalize on the burgeoning oral nicotine market. Investors are closely watching for further updates on the regulatory timeline and its impact on Zyn's sales projections.

• 3/8/2026POSITIVE
  Philip Morris CEO Says Cigarettes Belong in a Museum as Zyn and IQOS Surge

  Philip Morris International is accelerating its transition from traditional cigarettes to smoke-free alternatives like IQOS and Zyn, a strategic shift aimed at reducing harm by eliminating combustion. The company's CEO suggests cigarettes should eventually be phased out. This pivot is driven by the surging popularity of nicotine pouches and heated tobacco products. While public health experts raise concerns about long-term effects and persistent addiction risks, the company's focus on innovation and market adaptation in a heavily regulated industry signals a potentially strong future performance for investors.

• 2/24/2026NEUTRAL
  Here's How Much $100 Invested In Philip Morris Intl 5 Years Ago Would Be Worth Today

  A retrospective analysis of an investment in Philip Morris International offers crucial insights for long-term investors. While the headline doesn't provide specific details on the exact value of $100 invested five years ago, the significance of such studies lies in their ability to assess a company's historical performance. For investors, understanding how a stock has performed over time, including dividends and capital appreciation, is fundamental for shaping future expectations and refining portfolio strategies. Philip Morris, a tobacco giant with a growing emphasis on smoke-free products, represents an interesting case of market transition. Historical analysis helps contextualize the company's resilience and adaptability in the face of regulatory challenges and changing consumer habits, providing a basis for informed decisions.

• 2/24/2026POSITIVE
  Inside a $280 billion tobacco giant’s push to turn smokers into smoke-free customers

  Philip Morris International, the $280 billion tobacco giant, is charting an ambitious course towards a smoke-free future. The company's core strategy involves transitioning traditional cigarette smokers to smoke-free product alternatives, a critical move to adapt to an evolving regulatory and health landscape. This strategic pivot is considered vital for the company's long-term sustainability and growth, positioning it to capitalize on emerging trends within the industry. Investors should closely monitor the effectiveness of this transition, as success in the reduced-risk product market could unlock significant future value for the company.